View Older Stories View More Recent Stories
-
What Fed rate hikes mean for gold prices in 2027, according to Goldman
-
The Trade Desk (TTD) PT Raised to $13 at Guggenheim
-
Restaurant Brands International (QSR) PT Raised to $86 at Guggenheim
-
Eli Lilly (LLY) PT Raised to $1,284 at Guggenheim
-
Ultragenyx Pharma (RARE) PT Raised to $39 at Canaccord
-
Canaccord Reiterates Buy Rating on (NAGE)
-
Evercore ISI Starts Prelude Therapeutics (PRLD) at Outperform
-
EMA panel backs Novo Nordisk's Sogroya for children's growth disorder
-
Canaccord Reiterates Buy Rating on Inter Parfums (IPAR)
-
Canaccord Reiterates Buy Rating on Planet Fitness (PLNT)
-
Freedom Broker Starts Lightwave Logic (LWLG) at Buy, 'Polymer Speed at Silicon Scale'
-
Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
-
Needham Reiterates Hold Rating on Envista Holdings Corp. (NVST)
-
Northcoast Upgrades Badger Meter (BMI) to Buy
-
Mizuho Reiterates Outperform Rating on Intuit (INTU)
-
Mizuho Reiterates Outperform Rating on Brinker Int'l (EAT)
-
Jefferies on iPhone: 'Lead Time and Resale Prices Indicate Weakness', 'Duo will likely cannibalize 18P/PM'
-
CDT Equity partners with QIMA to test tapinarof drug combinations
-
Radisson to Participate in The Gentile Mining Investor Forum in London
-
Truist sees this stock unfairly punished in data center infrastructure sell-off
-
Americas Gold and Silver Continues Track Record of Significant Discoveries at the Galena Complex with a New Galena Mine Vein Discovery Grading 1,062 g/t Ag, 0.7% Cu over 1.3 Meters While Crescent Dril
-
Warren Buffett transitions to Berkshire’s chairman emeritus
-
Wells Fargo Starts Savers Value Village Inc (SVV) at Equal Weight
-
Needham Reiterates Buy Rating on HubSpot Inc (HUBS)
-
Stifel Upgrades Yeti Holdings Inc. (YETI) to Buy
-
CCB Int'l Starts Neurocrine Bio. (NBIX) at Outperform
-
FDA grants priority review to AstraZeneca's efzimfotase alfa for bone disease
-
House of Doge (HODO) files $100M mixed shelf
-
Wells Fargo Upgrades Kaiser Aluminum Corporation (KALU) to Equal Weight
-
Leerink Starts Eloxx Pharma (ELOX) at Outperform
-
GlucoTrack (GCTK) files for 43.45M share offering by selling stockholders
-
Evercore ISI Starts First Tracks Biotherapeutics (TRAX) at Outperform
-
BTIG Upgrades Etsy (ETSY) to Buy, 'Stock Pullback + Positive Tracking + Improved Cost Structure'
-
BTIG Reiterates Neutral Rating on Globus Medical (GMED)
-
William Blair Starts Perspective Therapeutics Inc (CATX) at Outperform
-
BTIG Downgrades Franklin BSP Realty Trust (FBRT) to Neutral
-
The Ensign Group (ENSG) Declares $0.0650 Quarterly Dividend; 0.1% Yield
-
Needham Upgrades Dynatrace Inc. (DT) to Buy
-
BofA Securities Starts Natural Grocers (NGVC) at Buy
-
DataMeds AI settles litigation, retiring $19M in liabilities
-
Anthropic has set up biology lab for physical experiments as it pursues drug ambitions - Reuters
-
Apple (AAPL) PT Raised to $380 at Evercore ISI
-
Warren Buffett named Chairman Emeritus at Berkshire Hathaway
-
U.S. weighs allowing most pharma licensing deals with China - Reuters
-
SK hynix launches corporate venture capital brand in Silicon Valley
-
Elbit Systems files shelf prospectus with Israeli regulators
-
TORM raises share capital via RSU exercise under incentive program
-
Hafnia raises Torm stake to 18.19% with 4.5M share purchase
-
DataMeds AI Litigation Settlement Extinguishes ~$19 million In Liabilities and Retires 364,099 Common Sharessked
-
Novarex Capital Partners Closes Second Financing Round With 16 Million Pounds Raised
